These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 31309339)
1. Unique clinical and autoantibody profile of a large Asian Indian cohort of scleroderma-do South Asians have a more aggressive disease? Janardana R; Nair AM; Surin AK; Prakash JAJ; Gowri M; Danda D Clin Rheumatol; 2019 Nov; 38(11):3179-3187. PubMed ID: 31309339 [TBL] [Abstract][Full Text] [Related]
2. Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody. Guillen-Del Castillo A; Pilar Simeón-Aznar C; Fonollosa-Pla V; Alonso-Vila S; Reverte-Vinaixa MM; Muñoz X; Pallisa E; Selva-O'allaghan A; Fernández-Codina A; Vilardell-Tarrés M Semin Arthritis Rheum; 2014 Dec; 44(3):331-7. PubMed ID: 25110305 [TBL] [Abstract][Full Text] [Related]
3. Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis. Showalter K; Hoffmann A; Rouleau G; Aaby D; Lee J; Richardson C; Dematte J; Agrawal R; Chang RW; Hinchcliff M J Rheumatol; 2018 Nov; 45(11):1572-1576. PubMed ID: 30275265 [TBL] [Abstract][Full Text] [Related]
4. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease. Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a commercial immunoassay for autoantibodies in Chinese Han systemic sclerosis population. Liu C; Hou Y; Yang Y; Xu D; Li L; Li J; Wen X; Zeng X; Zhang F; Li Y Clin Chim Acta; 2019 Apr; 491():121-125. PubMed ID: 30685360 [TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience. Chartrand S; Lee JS; Swigris JJ; Stanchev L; Fischer A Lung; 2019 Dec; 197(6):709-713. PubMed ID: 31583453 [TBL] [Abstract][Full Text] [Related]
7. Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma. Chong WH; Saha BK; Beegle S Am J Med Sci; 2023 Feb; 365(2):198-204. PubMed ID: 35276077 [TBL] [Abstract][Full Text] [Related]
8. A study on pulmonary complications of systemic sclerosis in eastern India. Ghosh A; Banerjee A; Biswas AK Indian J Chest Dis Allied Sci; 2014; 56(4):231-5. PubMed ID: 25962196 [TBL] [Abstract][Full Text] [Related]
9. Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease. Fischer A; Meehan RT; Feghali-Bostwick CA; West SG; Brown KK Chest; 2006 Oct; 130(4):976-81. PubMed ID: 17035427 [TBL] [Abstract][Full Text] [Related]
10. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity. Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682 [TBL] [Abstract][Full Text] [Related]
11. Clinical and autoantibody profiles of systemic sclerosis patients: A cross-sectional study from North India. Ghosh S; Tanna D; Telang K; Dhuria S; Gupta R Indian J Dermatol Venereol Leprol; 2023 Jul; ():1-7. PubMed ID: 37436007 [TBL] [Abstract][Full Text] [Related]
12. Anti-PM-Scl antibody in patients with systemic sclerosis. Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302 [TBL] [Abstract][Full Text] [Related]
13. Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: Inception cohort study. Wangkaew S; Euathrongchit J; Wattanawittawas P; Kasitanon N; Louthrenoo W Mod Rheumatol; 2016 Jul; 26(4):588-93. PubMed ID: 26561397 [TBL] [Abstract][Full Text] [Related]
14. Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study. Hamberg V; Sohrabian A; Volkmann ER; Wildt M; Löfdahl A; Wuttge DM; Hesselstrand R; Dellgren G; Westergren-Thorsson G; Rönnelid J; Andréasson K Arthritis Res Ther; 2023 Sep; 25(1):162. PubMed ID: 37667402 [TBL] [Abstract][Full Text] [Related]
15. Lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic features. Pereira DA; Dias OM; Almeida GE; Araujo MS; Kawano-Dourado LB; Baldi BG; Kairalla RA; Carvalho CR J Bras Pneumol; 2015; 41(2):151-60. PubMed ID: 25972968 [TBL] [Abstract][Full Text] [Related]
16. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis. Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677 [TBL] [Abstract][Full Text] [Related]
17. Autoantibodies in scleroderma and their association with the clinical profile of the disease. A study of 66 patients from southern Brazil. Skare TL; Fonseca AE; Luciano AC; Azevedo PM An Bras Dermatol; 2011; 86(6):1075-81. PubMed ID: 22281893 [TBL] [Abstract][Full Text] [Related]
18. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry. Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L; Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort. Vemulapalli S; Cohen L; Hsu V Scand J Rheumatol; 2017 Jul; 46(4):281-287. PubMed ID: 27635465 [TBL] [Abstract][Full Text] [Related]
20. Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registry. Castelino FV; VanBuren JM; Startup E; Assassi S; Bernstein EJ; Chung L; Correia C; Evnin LB; Frech TM; Gordon JK; Hant FN; Hummers LK; Khanna D; Sandorfi N; Shah AA; Shanmugam VK; Steen V Int J Rheum Dis; 2022 Feb; 25(2):163-174. PubMed ID: 34841681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]